| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.049 | 0.3 |